List of redirects

Jump to navigation Jump to search

Showing below up to 50 results in range #52,901 to #52,950.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. The Living Guidelines: Pharmacological rate control during atrial fibrillation View the Current CLASS IIa GuidelinesAtrial fibrillation rate control
  2. The Living Guidelines: Pharmacological rate control during atrial fibrillation View the Current CLASS IIb GuidelinesAtrial fibrillation rate control
  3. The Living Guidelines: Pharmacological rate control during atrial fibrillation View the Current CLASS I GuidelinesAtrial fibrillation rate control
  4. The Living Guidelines: Pregnant patients: View the Current CLASS IIb GuidelinesAtrial fibrillation pregnancy
  5. The Living Guidelines: Pregnant patients: View the Current CLASS I GuidelinesAtrial fibrillation pregnancy
  6. The Living Guidelines: Preventing Thromboembolism View the Current CLASS IIa GuidelinesAtrial fibrillation pharmacological treatment
  7. The Living Guidelines: Preventing Thromboembolism View the Current CLASS IIb GuidelinesAtrial fibrillation pharmacological treatment
  8. The Living Guidelines: Preventing Thromboembolism View the Current CLASS I GuidelinesAtrial fibrillation pharmacological treatment
  9. The Living Guidelines: Prevention of thromboembolism in patients with atrial fibrillation undergoing cardioversion: View the Current CLASS IIa GuidelinesAtrial fibrillation cardioversion
  10. The Living Guidelines: Prevention of thromboembolism in patients with atrial fibrillation undergoing cardioversion: View the Current CLASS I GuidelinesAtrial fibrillation cardioversion
  11. The Living Guidelines: Recommendations for Alternative Therapies for Chronic Stable Angina in Patients Refractory to Medical Therapy Who Are Not Candidates for PCI or Surgical RevascularizationView the Current CLASS IIb GuidelinesChronic stable angina treatment
  12. The Living Guidelines: Recommendations for Alternative Therapies for Chronic Stable Angina in Patients Refractory to Medical Therapy Who Are Not Candidates for PCI or Surgical Revascularization View the Current CLASS IIa GuidelinesChronic stable angina treatment
  13. The Living Guidelines: Recommendations for Echocardiography, Treadmill Exercise Testing, Stress Radionuclide Imaging, Stress Echocardiography Studies, and Coronary Angiography during Patient Follow-up View the Current CLASS III GuidelinesChronic stable angina patient follow-up
  14. The Living Guidelines: Recommendations for Echocardiography, Treadmill Exercise Testing, Stress Radionuclide Imaging, Stress Echocardiography Studies, and Coronary Angiography during Patient Follow-up View the Current CLASS IIa GuidelinesChronic stable angina patient follow-up
  15. The Living Guidelines: Recommendations for Echocardiography, Treadmill Exercise Testing, Stress Radionuclide Imaging, Stress Echocardiography Studies, and Coronary Angiography during Patient Follow-up View the Current CLASS IIb GuidelinesChronic stable angina patient follow-up
  16. The Living Guidelines: Recommendations for Monitoring of symptoms and anti anginal therapy during follow up View the Current CLASS III GuidelinesChronic stable angina patient follow-up
  17. The Living Guidelines: Recommendations for Monitoring of symptoms and anti anginal therapy during follow up View the Current CLASS IIb GuidelinesChronic stable angina patient follow-up
  18. The Living Guidelines: Recommendations for Monitoring of symptoms and anti anginal therapy during follow up View the Current CLASS I GuidelinesChronic stable angina patient follow-up
  19. The Living Guidelines: Recommendations for Revascularization with PCI and CABG in Asymptomatic Patients View the Current CLASS III GuidelinesChronic stable angina treatment
  20. The Living Guidelines: Recommendations for Revascularization with PCI and CABG in Asymptomatic Patients View the Current CLASS IIa GuidelinesChronic stable angina treatment
  21. The Living Guidelines: Recommendations for Revascularization with PCI and CABG in Asymptomatic Patients View the Current CLASS IIb GuidelinesChronic stable angina treatment
  22. The Living Guidelines: Recommendations for Revascularization with PCI and CABG in Asymptomatic Patients View the Current CLASS I GuidelinesChronic stable angina treatment
  23. The Living Guidelines: Recommendations for Revascularization with PCI and CABG in Patients with Chronic Stable Angina View the Current CLASS III GuidelinesChronic stable angina treatment
  24. The Living Guidelines: Recommendations for Revascularization with PCI and CABG in Patients with Chronic Stable Angina View the Current CLASS IIa GuidelinesChronic stable angina treatment
  25. The Living Guidelines: Recommendations for Revascularization with PCI and CABG in Patients with Chronic Stable Angina View the Current CLASS IIb GuidelinesChronic stable angina treatment
  26. The Living Guidelines: Recommendations for Revascularization with PCI and CABG in Patients with Chronic Stable Angina View the Current CLASS I GuidelinesChronic stable angina treatment
  27. The Living Guidelines: Recommendations for UA/NSTEMI in Drug and Substance Abusers View the Current CLASS III GuidelinesUnstable angina / non ST elevation myocardial infarction drug and substance abusers#ACC / AHA Guidelines (DO NOT EDIT)
  28. The Living Guidelines: Recommendations for UA/NSTEMI in Drug and Substance Abusers View the Current CLASS IIa GuidelinesUnstable angina / non ST elevation myocardial infarction drug and substance abusers#ACC / AHA Guidelines (DO NOT EDIT)
  29. The Living Guidelines: Recommendations for UA/NSTEMI in Drug and Substance Abusers View the Current CLASS IIb GuidelinesUnstable angina / non ST elevation myocardial infarction drug and substance abusers#ACC / AHA Guidelines (DO NOT EDIT)
  30. The Living Guidelines: Recommendations for UA/NSTEMI in Drug and Substance Abusers View the Current CLASS I GuidelinesUnstable angina / non ST elevation myocardial infarction drug and substance abusers#ACC / AHA Guidelines (DO NOT EDIT)
  31. The Living Guidelines: Recommendations for UA/NSTEMI in Prinzmetal’s Angina View the Current CLASS III GuidelinesUnstable angina / non ST elevation myocardial infarction prinzmetal's angina#ACC / AHA Guidelines (DO NOT EDIT)
  32. The Living Guidelines: Recommendations for UA/NSTEMI in Prinzmetal’s Angina View the Current CLASS IIb GuidelinesUnstable angina / non ST elevation myocardial infarction prinzmetal's angina#ACC / AHA Guidelines (DO NOT EDIT)
  33. The Living Guidelines: Recommendations for UA/NSTEMI in Prinzmetal’s Angina View the Current CLASS I GuidelinesUnstable angina / non ST elevation myocardial infarction prinzmetal's angina#ACC / AHA Guidelines (DO NOT EDIT)
  34. The Living Guidelines: Recommendations for UA/NSTEMI in patients with Cardiovascular Syndrome X View the Current CLASS III GuidelinesUnstable angina / non ST elevation myocardial infarction cardiovascular syndrome x#ACC / AHA Guidelines (DO NOT EDIT)
  35. The Living Guidelines: Recommendations for UA/NSTEMI in patients with Cardiovascular Syndrome X View the Current CLASS IIb GuidelinesUnstable angina / non ST elevation myocardial infarction cardiovascular syndrome x#ACC / AHA Guidelines (DO NOT EDIT)
  36. The Living Guidelines: Recommendations for UA/NSTEMI in patients with Cardiovascular Syndrome X View the Current CLASS I GuidelinesUnstable angina / non ST elevation myocardial infarction cardiovascular syndrome x#ACC / AHA Guidelines (DO NOT EDIT)
  37. The Living Guidelines: Recommendations for choosing diagnostic tests during follow up in patients with Chronic Stable Angina View the Current CLASS I GuidelinesChronic stable angina patient follow-up
  38. The Living Guidelines: STEMI Anticoagulants as Ancillary Therapy View the Current CLASS I GuidelinesST elevation myocardial infarction anticoagulant and antithrombotic therapy
  39. The Living Guidelines: STEMI Anticoagulants for STEMI patients who do not go reperfusion therapy View the Current CLASS III GuidelinesST elevation myocardial infarction management of patients who were not reperfused
  40. The Living Guidelines: STEMI Anticoagulants for STEMI patients who do not go reperfusion therapy View the Current CLASS IIa GuidelinesST elevation myocardial infarction management of patients who were not reperfused
  41. The Living Guidelines: STEMI Antiplatelet Agents / Anticoagulants Therapy: Aspirin View the Current CLASS IIa GuidelinesST elevation myocardial infarction aspirin therapy
  42. The Living Guidelines: STEMI Antiplatelet Agents / Anticoagulants Therapy: Aspirin View the Current CLASS I GuidelinesST elevation myocardial infarction aspirin therapy
  43. The Living Guidelines: STEMI Antiplatelet Agents / Anticoagulants Therapy: Clopidogrel View the Current CLASS IIa GuidelinesST elevation myocardial infarction secondary prevention
  44. The Living Guidelines: STEMI Antiplatelet Agents / Anticoagulants Therapy: Clopidogrel View the Current CLASS I GuidelinesST elevation myocardial infarction secondary prevention
  45. The Living Guidelines: STEMI Antiplatelet Agents / Anticoagulants Therapy: Warfarin View the Current CLASS I GuidelinesST elevation myocardial infarction secondary prevention
  46. The Living Guidelines: STEMI Facilitated PCI View the Current CLASS III GuidelinesST elevation myocardial infarction facilitated percutaneous coronary intervention
  47. The Living Guidelines: STEMI Facilitated PCI View the Current CLASS IIb GuidelinesST elevation myocardial infarction facilitated percutaneous coronary intervention
  48. The Living Guidelines: STEMI Immediate (or Emergency) Invasive Strategy and Rescue PCI View the Current CLASS III GuidelinesST elevation myocardial infarction percutaneous coronary intervention following fibrinolytic administration
  49. The Living Guidelines: STEMI Immediate (or Emergency) Invasive Strategy and Rescue PCI View the Current CLASS IIa GuidelinesST elevation myocardial infarction percutaneous coronary intervention following fibrinolytic administration
  50. The Living Guidelines: STEMI Immediate (or Emergency) Invasive Strategy and Rescue PCI View the Current CLASS IIb GuidelinesST elevation myocardial infarction percutaneous coronary intervention following fibrinolytic administration

View ( | ) (20 | 50 | 100 | 250 | 500)